IP Library › Granted Patent US 12,728,148
Granted Patent B2
US 12,728,148 · App. 17/780,764 · Granted Sep 8, 2026

Non-rinsed veterinary compositions

Inventors: Emeline Commeurec (Libourne, FR); Nadége Maubert (Libourne, FR)
Assignee: CEVA SANTE ANIMALE
A61K36/8968A61K9/0017A61K31/164A61K47/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,728,148
App. No.
17/780,764
Filed
Nov 16, 2022
Granted
Sep 8, 2026
Kind
B2
Art Unit
1617
USPC
424/725
Abstract

The invention relates to the veterinary field and, more particularly, non-rinsed compositions comprising an active ingredient obtained from Ophiopogon japonicus , panthenol and saccharide isomerate, for non-human mammals. The invention also relates to a method for treating the coat of non-human mammals by applying said non-rinsed compositions to the coat and/or the skin.

Claims (15)

1 . A non-rinsed veterinary composition comprising an active ingredient obtained from Ophiopogon japonicus , panthenol and saccharide isomerate, wherein the composition comprises from 0.3 to 0.8 wt % panthenol and from 0.1 to 1 wt % saccharide isomerate, with respect to the total weight of the composition.

2 . The veterinary composition according to claim 1 , comprising at least 0.1 wt. % active agent obtained from Ophiopogon japonicus with respect to the total weight of the composition.

3 . The veterinary composition according to claim 1 , comprising between 0.3 wt % and 0.9 wt % saccharide isomerate, with respect to the total weight of the composition.

4 . The veterinary composition according to claim 1 , wherein the composition is in the form selected from a lotion, a gel, a cream, or a mousse.

5 . The veterinary composition according to claim 1 , wherein the composition comprises one or more surfactant(s) selected from amphoteric surfactants of the betaine type, carboxylic anionic surfactants, alkyl (poly) glucoside nonionic surfactants, and mixtures thereof.

6 . The veterinary composition according to claim 5 , wherein the surfactant is selected from sodium lauroyl sarcosinate, capryl/capramidopropyl betaine, caprylyl/capryl glucoside, or mixtures thereof.

7 . The veterinary composition according to claim 5 , wherein the surfactant is present in amounts of from 0.1 to 10 wt. %, with respect to the total weight of the composition.

8 . The veterinary composition according to claim 1 , wherein the composition further comprises cationic galactomannan gums.

9 . The veterinary composition according to claim 1 , wherein the composition is provided in the form of a mousse.

10 . A method for treating the skin and/or the coat of a non-human mammal by applying the composition according to claim 1 to the skin and/or the coat of said mammal.

11 . A method for reducing and/or preventing the formation and/or the adhesion of biofilms of pathogenic bacteria, or for reducing the presence of pathogenic bacteria on the skin or the coat, in a non-human mammal by applying the veterinary composition according to claim 1 to the skin or the coat of a non-human mammal.

12 . The method according to claim 11 , characterized in that the pathogenic bacteria are selected from Staphylococcus aureus and/or Staphylococcus pseudintermedius.

13 . A veterinary treatment device for treating the skin and/or the coat of a non-human mammal, comprising:

a veterinary composition according to claim 5 ; and

a mousse dispenser, allowing distribution of said composition in the form of a mousse.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2023
From: COMMEUREC, EMELINE; MAUBERT, NADÉGE
To: CEVA SANTE ANIMALE
Reel/Frame 062304/0428 →
Priority Claims (1)
EP 19212297 · Nov 28, 2019 · regional
Continuity (1)
Related Publication 20230127281A1 · Apr 27, 2023
References Cited (20)
US 20060074029A1 · Leece · 2006 [cited by applicant]
US 20060275235A1 · Takeda et al. · 2006 [cited by applicant]
US 20100239695A1 · Vielhaber · 2010 [cited by examiner]
US 20110097281A1 · Neubourg · 2011 [cited by examiner]
US 20150147286A1 · Barrera · 2015 [cited by examiner]
US 20150297652A1 · Balaraman · 2015 [cited by applicant]
US 20180072817A1 · Lin · 2018 [cited by examiner]
US 20190110967A1 · Chiou · 2019 [cited by applicant]
CN 109602627A · 2019 [cited by applicant]
JP 2005126329A · 2005 [cited by applicant]
JP 2013521259A · 2013 [cited by applicant]
WO 2004099258A1 · 2006 [cited by applicant]
WO 2011107522A2 · 2011 [cited by applicant]
WO WO2017121965A1 · 2017 [cited by examiner]
Ebner Fritz et al. “Topical use of dexpanthenol in skin disorders” American Journal of Clinical Dermatology, ADIS, US, vol. 3, No. 6, Jan. 1, 2002 (Jan. 1, 2002), pp. 427-433 DOI: 10.2165/00I 2807I-200203060-00005 ISSN:… [cited by applicant]
Unknown. “Pentavitin binds to keratin in skin to keep the moisture balance” Jan. 1, 2009 (Jan. 1, 2009), pp. 1-2, Retrieved from the Internet: https://www.cosmeticsonline.com.br/subcategorias/S UB19_DSM%20PENTAVITIN.pdf. [cited by applicant]
Yakugaku Zasshi, “Surfactant-induced Itching and the Involvement of Histamine Released from Keratinocytes”, 132(11); 1225-1230 (2012) The Pharmaceutical Society of Japan. [cited by applicant]
Office Action for Australian Patent Application No. 2020392433 mailed Sep. 16, 2025. [cited by applicant]
“Perfection Difference Cream”, MINTEL GNPD, Available from the Internet: https://www.gnpd.com/sinatra/recordpage/3696789/, Published Jan. 2016, Last Retrieved Sep. 8, 2025. [cited by applicant]
“Firming & Moisturizing Mask”, MINTEL GNPD, Available from the Internet: https://www.gnpd.com/sinatra/recordpage/4355519/, Published Oct. 2016, Last Retrieved Oct. 8, 2025. [cited by applicant]